BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

October 25, 2021 | News

Columbia opens its third and largest hospital in Jiaxing, China

Jiaxing Kaiyi Hospital is licensed for 500 beds with a construction area of 112,000 square meters. It is built in accordance to Joint Commission Inte...

October 25, 2021 | News

International Biopharma Industry Week Shanghai 2021 Opens

Under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is...

October 15, 2021 | News

Chinese Researcher Releases Latest Research Results on Early Screening for Multiple Cancers

Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS...

October 14, 2021 | News

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction

The cooperation involved rare disease registration and research, development of single disease diagnosis and treatment guidelines and regulations, doctor t...

October 12, 2021 | News

China sets ambitious biomedical goals with support of key companies

The annual business revenue of the biomedical industry in Binhai is expected to reach 100 billion yuan ($15.44 billion) by 2025 with the ...

October 01, 2021 | News

Foresees the Future Trend of Laboratory Technology

NIKYANG made a stunning appearance at the 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) with its latest innovative labo...

September 28, 2021 | News

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002

Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...

September 27, 2021 | News

Johnson & Johnson Innovation Announces Awardees of the Digital Technologies of Tomorrow QuickFire Challenge

Johnson & Johnson Innovation LLC together with Johnson & Johnson Medical Shanghai Ltd. today at AmCham China's Technology and Innovation Summit nam...

September 24, 2021 | News

Everest to support future development and commercialization globally for the treatment of renal diseases

Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...

September 17, 2021 | News

Sartorius to open new Application and Service Hub in Shanghai

▪ Supporting Chinese customers with cutting-edge innovations to accelerate technological breakthroughs in life science research and biopharma proce...

September 16, 2021 | News

Allianz Partners expands its Digital Health Assistant to ten markets in Asia-Pacific

Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals This digital ...

September 16, 2021 | News

Clover Biopharmaceuticals to Produce COVID-19 Vaccine

Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, toda...

September 14, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

Stay Connected